Záznam dôkazov metódy

Risk-adjusted Phase IV study

A risk-adjusted Phase IV study is an observational or semi-experimental post-marketing study conducted after a drug or device has received regulatory approval. It uses statistical risk-adjustment techniques — such as propensity score matching, inverse probability weighting, or multivariable regression — to control for confounding by indication and baseline patient differences, thereby producing more credible safety, effectiveness, and utilization estimates than unadjusted real-world analyses.

Sources recorded, not reviewed

Zdrojový záznam

Citácie skopírované doslovne zo zdrojového záznamu metódy. Nevyplýva z nich žiadne overenie na úrovni tvrdenia.

Risk-adjusted Phase IV Post-marketing Study

Taxonomický záznam metódy · process-pipeline / epidemiology

Strom, B. L. (Ed.). (2005). Pharmacoepidemiology (4th ed.). John Wiley & Sons. · ISBN 978-0470863107
Austin, P. C. (2011). An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behavioral Research, 46(3), 399–424. · DOI 10.1080/00273171.2011.568786

Otvoriť celú metódu

Spracované tvrdenia

Tvrdenia uložené v registri dôkazov, každé s vlastným hodnotením.

Zatiaľ žiadne spracované tvrdenia

Tento pohľad nevymýšľa hodnotenie tvrdenia, ak register žiadne nemá.

Súvisiace metódy

Vygenerované z grafu metód a zobrazené ako vzťahy navrhnuté strojom – nevyplýva z nich žiadne tvrdenie o dôkaze.

Taxonomic bucketCohort Studymachine-suggested · Relational suggestion, not evidence.See alsoInverse Probability Weightingmachine-suggested · Relational suggestion, not evidence.Same method familyPropensity Score Matchingmachine-suggested · Relational suggestion, not evidence.